Sunday - June 2, 2024

Metabolites of [3-(4-(2-Butyl-1-[4-(4-Chloro-Phenoxy)-Phenyl]-1h-Imidazol-4-Yl)-Phenoxy)-Propyl]-Diethyl-Amine

2024-04-30

ALEXANDRIA, Virginia, April 30 -- VTV THERAPEUTICS LLC, High Point, North Carolina has been assigned a patent (No. US 11970457 B2, initially filed Oct. 27, 2022) developed by five inventors William Kenneth Banner, Greensboro, North Carolina; Bapu Gaddam, Ellicott City, Maryland; Dharma Rao Polisetti, High Point, North Carolina; Robert Carl Andrews, Jamestown, North Carolina; and Samuel Victory, Winston-Salem, North Carolina, for "Metabolites of [3-(4-(2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H- . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Metabolites of [3-(4-(2-Butyl-1-[4-(4-Chloro-Phenoxy)-Phenyl]-1h-Imidazol-4-Yl)-Phenoxy)-Propyl]-Diethyl-Amine

Information Request Form

Copyright Targeted News Service 2024